An Evaluation of the Initiation and Use of Sacubitril/Valsartan in an Inpatient Heart Failure Population: A Retrospective Medication Use Evaluation
Saved in:
| Main Authors: | Tara Snyder, Krissy-Ann Thornby, Amy Henneman, Robert Thornby |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
California Pharmacists Association
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/4c0713ef4a464a198358a531163db999 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal protective effect of sacubitril/valsartan in patients with heart failure
by: Hui-Ling Hsieh, et al.
Published: (2021) -
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
by: Cuthbert JJ, et al.
Published: (2020) -
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
by: Mauro Gori, et al.
Published: (2021) -
Sacubitril/valsartan in real-life clinical practice
by: Yüksel Çavuşoğlu
Published: (2021) -
Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red
by: Kateryna Peleshok, et al.
Published: (2021)